51-55 of 55 results

Audio: D'Arcy v Myriad: The High Court rules on gene patenting
Insight 07 Oct 2015

Allens Partner Dr Trevor Davies discusses why the High Court overturned the decision and what it means for the biotech industry ...

Isolated genetic material confirmed as patentable
Insight 12 Sep 2014

In a unanimous decision the Full Federal Court has confirmed that genetic materials in their isolated form remain patentable in Australia The decision related to an appeal from an earlier Federal Court decision in which it was found isolated nucleic acids to be a manner of manufacture as required by ...

The ending point for 'starting point'
Insight 01 Sep 2014

The Full Federal Court has published its much-anticipated judgment in the AstraZeneca v Apotex appeal A bench of five judges heard the appeal in contrast to the usual three judges in order to be able to clarify or overrule if appropriate an earlier Full Court decision relating to the correct test ...

Allens insights: Implementation of Australia's PCEHR system reviewed
Insight 11 Aug 2014

At the end of 2013 the Federal Minister for Health announced a panel review into Australias Personally Controlled Electronic Health Record PCEHR system to consider implementation and uptake issues The subsequent report made public in May 2014 puts forward 38 recommendations to address the issues ...

TGA confirms its approach to disclosure of commercially confidential information
Insight 21 May 2014

The Therapeutic Goods Administration has released the final version of a document outlining its approach to the disclosure of commercially confidential information including information provided by medicine sponsors This follows the release of a draft version in June 2013 and a period of public and ...